Your first paragraph $””””””” is very pertinent, the question then becomes, - what is Biotron going to do next if there is no commercial deal outcome?. It has to have something going on to remain relevant to SHs. I can’t imagine “working on the next gen HIV drug” will cut the mustard with already weary SHs, and the hep B program hasn’t done anything in years.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-54
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
